HomeNewsBusinessStartupCOVID-19 impact | CureFit trims workforce, shuts down centres across India and UAE

COVID-19 impact | CureFit trims workforce, shuts down centres across India and UAE

The company said that these decisions were taken to ensure long-term viability of the business.

May 04, 2020 / 18:10 IST
Story continues below Advertisement

Digital fitness and healthcare startup Cure Fit said that it has shut down its operations across small towns in India and the United Arab Emirates due to the ongoing lockdown caused by the COVID-19 outbreak.

While the founders have taken a 100 percent pay cut, the management team has taken a 50 percent pay cut followed by the rest of the staff, who have taken anywhere between 20 to 30 percent cuts depending on the seniority, the company said in the statement.

Story continues below Advertisement

It added that around 10 percent of its trainers have been asked to leave and the remaining 90 percent have been put on a fixed plus variable model of payments.

The company said that these decisions were taken to ensure long-term viability of the business.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show